Announcements Trials

Browse Landscape

Phase

Status

Unknown 1 Terminated 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Tuberous Sclerosis 1 Neoplasms 1 Epilepsy 1

Interventions

Cisplatin 504 Cyclophosphamide 353 Radiotherapy 349 Carboplatin 347 Capecitabine 328 Oxaliplatin 319 Paclitaxel 316 Gemcitabine 315 Docetaxel 308 Fluorouracil 281 apatinib 240 Drug Therapy 239 Bevacizumab 224 camrelizumab 212 Etoposide 199 Irinotecan 176 Doxorubicin 174 Dexamethasone 159 Leucovorin 158 sintilimab 140 Pemetrexed 136 Cytarabine 136 pembrolizumab 135 anlotinib 135 toripalimab 124 S 1 (combination) 119 Neoadjuvant Therapy 119 Vincristine 118 Rituximab 114 Radiosurgery 113

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Interventional × Vigabatrin × Clear all

NCT04987463 2024-02-08

ViRap

Children's Memorial Health Institute, Poland

Phase 2/3 Unknown

Epilepsy, Neoplasms, Tuberous Sclerosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡